International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Reviewer Referral Program
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
GSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 6
November-December 2024
Indexing Partners
A Review on Intellectual Property Rights
Author(s) | Pratik C. Waghmare, Shravan j. Somani, Abhijit R. Rode, Karishma R. Gulave |
---|---|
Country | India |
Abstract | This review article delves into the complex and ever-evolving field of intellectual property rights (IPR) as they relate to the pharmaceutical industry. The article begins by examining the history of IPR in pharmacy, highlighting the key developments and milestones that have shaped the landscape of pharmaceutical intellectual property law over time. From there, the article explores the different types of IPR that are relevant in the pharmaceutical industry, including patents, trademarks, and copyrights. The article then moves on to discuss the critical role that IPR plays in driving innovation and economic growth in the pharmaceutical sector. This section provides a comprehensive overview of how IPR protections incentivize research and development, encourage investment in new drugs and therapies, and ultimately help to improve global health outcomes. However, the article also delves into the challenges and controversies surrounding IPR in the pharmaceutical industry. This includes discussions of issues such as access to essential medicines, high drug prices, and the tension between intellectual property rights and public health concerns. Finally, the article considers the future of IPR in pharmacy, including emerging trends and developments that will likely shape the field in the coming years. This section touches on issues such as personalized medicine, artificial intelligence, and the increasing importance of data as an asset in the pharmaceutical industry. Overall, this review article provides a comprehensive and insightful overview of intellectual property rights in the pharmaceutical industry, making it an invaluable resource for anyone interested in this important and dynamic area of the law. Keywords: - Innovation, Economic growth, Drug pricing, public health, Personalized medicine, Artificial intelligence, Data assets |
Keywords | Keywords: - Innovation, Economic growth, Drug pricing, public health, Personalized medicine, Artificial intelligence, Data assets |
Field | Medical / Pharmacy |
Published In | Volume 5, Issue 3, May-June 2023 |
Published On | 2023-05-04 |
Cite This | A Review on Intellectual Property Rights - Pratik C. Waghmare, Shravan j. Somani, Abhijit R. Rode, Karishma R. Gulave - IJFMR Volume 5, Issue 3, May-June 2023. DOI 10.36948/ijfmr.2023.v05i03.2831 |
DOI | https://doi.org/10.36948/ijfmr.2023.v05i03.2831 |
Short DOI | https://doi.org/gr7hdf |
Share this
E-ISSN 2582-2160
doi
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.